Skip to content

13F-HR filed by ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 28 holding rows worth $278,400,000.

Accession
0000919574-15-006298
Filed
2015-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2015

A holdings report, 28 entries on the cover page, a total value of $278,400,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $278,400,000 with VALUE read as thousands by filing date, 13F file number 028-16738. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS150,000$30,884,000thousands by filing dateput
SPECTRUM PHARMACEUTICALS INC84763A108COM4,436,000$30,342,000thousands by filing date
APOLLO GROUP INC037604105CL A1,270,000$16,358,000thousands by filing date
EASTMAN KODAK CO277461406COM NEW960,000$16,128,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM1,142,000$14,492,000thousands by filing date
ANTARES PHARMA INC036642106COM6,400,000$13,312,000thousands by filing date
IGNYTA INC451731103COM870,000$13,128,000thousands by filing date
FTD COS INC30281V108COM458,000$12,911,000thousands by filing date
THERAVANCE BIOPHARMA INCG8807B106COM974,000$12,681,000thousands by filing date
QLOGIC CORP747277101COM812,000$11,522,000thousands by filing date
AVANTAX INC095229100COMMON STOCK700,000$11,305,000thousands by filing date
SKULLCANDY INC83083J104COM1,406,000$10,784,000thousands by filing date
BED BATH & BEYOND INC690370101COM446,000$10,053,000thousands by filing date
XENOPORT INC98411C100COM1,600,000$9,808,000thousands by filing date
ABERCROMBIE & FITCH CO CL A002896207Stock412,000$8,862,000thousands by filing date
HEALTHWAYS INC422245100COM640,000$7,667,000thousands by filing date
LIPOCINE INC NEW53630X104CMN850,000$7,293,000thousands by filing date
INVENTURE FOODS INC461212102COM618,000$6,273,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM186,000$6,199,000thousands by filing date
DEMAND MEDIA INC24802N208Cmn968,000$6,156,000thousands by filing date
SUNOPTA INC8676EP108COM424,000$4,550,000thousands by filing date
PENNEY J C INC708160106COM500,000$4,235,000thousands by filing date
BIOTIE THERAPIES OYJ09074D103SPONSORED ADR200,000$3,994,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM400,000$3,184,000thousands by filing date
QLT INC746927102COMMON STOCK660,000$2,726,000thousands by filing date
INSPIREMD INC45779A309COM6,560,000$1,837,000thousands by filing date
Female Health Company314462102COM600,000$1,080,000thousands by filing date
REACHLOCAL INC75525F104COM202,000$636,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-15-006298this filing2015-08-14acceptance time not in the bulk data set